Pfizer BNT 162b2 COVID-19 vaccine–induced fulminant myopericarditis: A case study

The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purifi...

Full description

Saved in:
Bibliographic Details
Published inCritical care and resuscitation Vol. 25; no. 3; pp. 155 - 157
Main Authors Montarello, Natalie L., Wong, Hao Zheng, Jeffries, Ashlee, Perkins, Griffith B., Hissaria, Pravin, Stokes, Michael B., Raith, Eamon, Teo, Karen, Bradley, Julie
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2023
Elsevier
Subjects
Case Report
Online AccessGet full text

Cover

More Information
Summary:The use of mRNA COVID-19 vaccine can on rare occasions cause life-threatening, fulminant myopericarditis. This case report demonstrates previously reported benefit of early use of venoarterial extracorporeal membrane oxygenation mechanical assistance and supports the use of intravenous highly purified immunoglobulin pharmacotherapy to help achieve a good clinical outcome.
ISSN:1441-2772
2652-9335
DOI:10.1016/j.ccrj.2023.06.005